Proof-of-concept computational approaches identify TDP1 inhibitors in biomolecules, suggesting new strategies for biochemical research.
This paper introduces several proof-of-concept (PoC) computational methods intended to offer biochemical researchers straightforward, time- and cost-effective strategies to accelerate their work. While Machine Learning (ML) models were developed, the study's central purpose was to explore approaches for the identification of desirable functional groups/fragments in small biomolecules regarding a specific functionality, which, in this case, was human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibition. This was achieved primarily by tokenising IUPAC names to generate features. Additionally, the applicability of the CID_SID ML model for predicting TDP1 activity was developed and explored. Since these computational approaches were not experimentally validated due to a lack of appropriate laboratory facilities, they are presented as open proposals for further laboratory investigation.
No takes yet. Share an insight, caveat, or question.
Ivanova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: